EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Cegedim SA (0DYQ) fair value: what the stock is really worth

As of Oct 1, 2026: fair value of Cegedim SA €17.53, price €11.22, upside +56.2%, quality 57 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Industrials · GB · Home France · ISIN FR0000053506

CS Broad data Sep 24, 2026

Cegedim SA

0DYQ · LSE

Clearly undervaluedStrong Fair Value upside, but quality is only moderate.

✓Fair value €17.53 · Strongly undervalued (+56.2%)
!Quality 57/100
!Mixed Growth (revenue 5y +5.5 %/yr)
!Thin margins · 1.5% net margin (TTM)
✓Moderate debt · generates free cash flow
!Narrow moat 30/100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€28.23 €8.60 Fair Value €17.53 Dec 2020 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range €8.60 – €28.23 · fair‑value band €10.77 – €27.79 · the €11.22 price screens below the €17.53 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B in France, rest of Europe, and internationally. It operates through Health Insurance, HR and E-Services; Healthcare Professionals; and Cloud & Support segments.

Show more

Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B in France, rest of Europe, and internationally. It operates through Health Insurance, HR and E-Services; Healthcare Professionals; and Cloud & Support segments. The Health Insurance, HR and E-Services segment markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals. This segment also provides solutions for IT services and hosting, digitization, human resources and payroll management outsourcing, electronic data exchange, and data processing services. The Healthcare Professionals division sells management software, databases, and solutions to doctors, paramedical professionals, pharmacists, and healthcare facilities. It also operates as a business software publisher for healthcare and insurance professionals. The company was incorporated in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SAS.

Stock analysis

Cegedim SA (0DYQ) currently trades at €11.22, while our model-based Fair Value estimate is €17.53, implying the stock looks roughly 36.0% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of €57.18 per share, and 20 of the 23 models we run sit above the €11.22 price.

Bear case: the Earnings-Based group reads lowest at €9.59, and 3 of the 23 models stay below the price. Evidence for this calculation is high.

Scenario range: €10.77 (bear) to €27.79 (bull), the price of €11.22 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 57/100 (solid quality), in the Industrials sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Cegedim SA reported revenue of €649M in FY2025 versus €525M in FY2021, a compound +5.5%/yr. Reported net income was €9.4M in FY2025, compounding −22.6%/yr from FY2021.

Key figures

Market cap €154M · P/E ratio 0.1 · EPS (TTM) €1.90 · Net margin 1.4% · Return on equity 2.9% · Return on assets (EBIT) 3.6% · Operating margin 6.3% · Revenue (TTM) €649M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).

What moves the price

The share trades about 24% below its 52-week high and 30% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −44% fair-value upside, at 56%, 0DYQ screens cheaper than that median.

Fair Value models

Bear €10.77 Fair Value €17.53 Bull €27.79
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (€1.44 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF €69.40 €90.05 €113.26 82
Growth DCF €70.50 €89.45 €109.97 80
Owner Earnings €42.23 €55.51 €70.45 78
All 23 models by family
DCF Models
FCF DCF €69.40 €90.05 €113.26 82
Owner Earnings €42.23 €55.51 €70.45 78
5Y Revenue Exit €40.14 €51.66 €64.75 74
5Y EBITDA Exit €68.24 €100.69 €135.93 76
5Y P/E Exit €33.06 €39.31 €44.91 72
10Y Revenue Exit €52.66 €64.25 €76.77 68
10Y EBITDA Exit €68.08 €92.29 €120.32 69
10Y P/E Exit €49.40 €57.18 €64.64 65
Earnings-Based
Graham-Dodd €4.59 €9.59 €12.14 66
PEG = 1.0 €1.43 €2.04 €2.65 57
EPV €10.17 €12.20 €13.85 74
Multiples
P/E Multiple €10.63 €14.17 €17.71 63
P/S Multiple €8.60 €11.47 €14.34 58
P/B Multiple €8.60 €11.47 €14.34 55
EV/EBIT €26.80 €37.99 €49.17 65
EV/EBITDA €78.59 €107.04 €135.48 67
EV/Revenue €17.20 €27.46 €37.72 53
Asset-Based
NCAV (Graham) €10.13 €13.57 €20.26 54
Growth DCF
Growth DCF €70.50 €89.45 €109.97 80
Rev-Margin DCF €40.14 €53.43 €68.02 74
Economic Profit
Residual Income €13.43 €12.70 €12.40 71
ROIC Compounder €10.17 €12.20 €13.85 72
Growth Earnings
Growth-Adj P/E €7.79 €11.13 €14.47 67

Open the full fair value analysis →

Notify me when 0DYQ reaches fair value

Put 0DYQ on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 57/100

Of which business quality 55 · Market factors (momentum, volatility) 45

Profitability 24
Margins and returns on capital today
Quality Growth 46
Are margins and returns improving?
Cashflow 84
Earnings quality: real cash, not paper profit
Fin. Strength 31
Balance sheet, leverage, solvency risk
Investment 90
Disciplined investing over empire-building
Low Volatility 63
Calm price path (market factor)
Momentum 35
Price trend over the last 3–12 months (market factor)
52W Momentum 41
Distance to the 52-week high (market factor)
Net Issuance 79
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 64/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−0.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.5%
Start year 2020 (pandemic). Over 10 years: +4.3% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.9%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−2.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−2.7%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−2.7% vs −6.9%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.8% → 6%
Start year 2020 (pandemic)

Watch 0DYQ, get fair value alerts →

Compare Cegedim SA with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Machinery stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
CHEMTECH CHEMTECH ₹59.59 ₹33.64 −44%
INLCM INLCM ₹258.90 ₹56.93 −78%
Contemporary Amperex Technology Co 300750 ¥291.11 ¥695.24 +139%
Delta Electronics (Thailand) Public Company DELTA 263.00 THB 38.64 THB −85%
Larsen & Toubro Limited LT ₹3,876 ₹1,994 −49%
Samsung C&T Corporation 028260 367,000 KRW 159,718 KRW −56%
Adani Ports and Special Economic Zone Limited ADANIPORTS ₹1,738 ₹1,041 −40%
Hanwha Aerospace Co 012450 1,021,000 KRW 678,284 KRW −34%
ASELSAN Elektronik Sanayi ve Ticaret Anonim Sirketi ASELS 372.25 TRY 63.11 TRY −83%
HD Hyundai Heavy Industries Co 329180 441,000 KRW 485,100 KRW +10%

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Cegedim SA Fair Value". https://www.fairvalue-calculator.com/stock/0DYQ

Frequently asked questions

Is Cegedim SA (0DYQ) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of €17.53 versus a price of €11.22, about +56% upside (undervalued).
What is the fair value of 0DYQ?
Our model-based fair value for Cegedim SA is €17.53 (as of Sep 24, 2026), built from audited fundamentals. The current price: €11.22.
What is the quality score of 0DYQ?
Cegedim SA has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cegedim SA (0DYQ)?
Our model-based price target is the fair value of €17.53 (as of Sep 24, 2026) from 23 valuation models. Cautious scenario €10.77, optimistic scenario €27.79. It is a calculation from audited fundamentals, not an analyst target.
What is the Cegedim SA stock forecast for 2026?
Our models put fair value at €17.53, about +56% upside versus a price of €11.22 (undervalued). Cautious scenario €10.77, optimistic scenario €27.79. The calculation is refreshed regularly with new filings.
What is the revenue of Cegedim SA (0DYQ)?
Cegedim SA reported trailing-twelve-month revenue of about €649M (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Cegedim SA (0DYQ)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cegedim SA it is €17.53 per share (as of Sep 24, 2026), against a price of €11.22. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Cegedim SA stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 0DYQ trades below its calculated fair value: price €11.22, fair value €17.53, a gap of about +56% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0DYQ?
No. The price is what the market pays today (€11.22); the fair value is what the company's own numbers justify (€17.53). For Cegedim SA the two are €6.31 per share apart. That gap is exactly why we show both numbers side by side.
How much is Cegedim SA worth?
The market values Cegedim SA at about €154M (market capitalisation, as of Sep 24, 2026). Per share that is €11.22; our models calculate a fair value of €17.53 per share.
What do the bullish and bearish scenarios say about 0DYQ?
Our models span a range for Cegedim SA: cautious scenario €10.77, base €17.53, optimistic €27.79 per share (as of Sep 24, 2026, price €11.22). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is 0DYQ from its 52-week high?
Cegedim SA trades at €11.22, about 24% below its 52-week high of €14.80 and 30% above the low of €8.60 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of €17.53 is for.
Which stocks are comparable to Cegedim SA?
From the same area (Industrials) we also value CHEMTECH, INLCM, Contemporary Amperex Technology Co, Delta Electronics (Thailand) Public Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cegedim SA stock attractive at the current price?
The data as of Sep 24, 2026: price €11.22, calculated fair value €17.53 (+56%), Quality Score 57/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0DYQ calculated?
We run Cegedim SA through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €17.53, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Cegedim SA currently trades 36 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cegedim SA (0DYQ)?
The closing price on Oct 1, 2026 was €11.22. Our model-based fair value is €17.53, about +56% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cegedim SA right now?
Solid quality (57/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (€10.77 to €27.79) leaves room in how you read the outcome.

Key figures of Cegedim SA

How large is the market capitalisation of Cegedim SA (0DYQ)?
The market capitalisation of Cegedim SA is €154M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/E ratio of Cegedim SA (0DYQ)?
The price-to-earnings ratio of Cegedim SA is 0.1 (as of Jul 24, 2026). Price to earnings: how many years of current profit you pay for the stock. A P/E of 10 means ten years of profit.
What are the earnings per share of Cegedim SA (0DYQ)?
Earnings per share at Cegedim SA are €1.90 (price ÷ EPS = P/E 0.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Cegedim SA (0DYQ)?
The net margin of Cegedim SA is 1.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cegedim SA (0DYQ)?
The return on equity (ROE) of Cegedim SA is 2.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cegedim SA (0DYQ)?
On an EBIT basis the return on assets of Cegedim SA is 3.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cegedim SA (0DYQ)?
The operating margin of Cegedim SA is 6.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cegedim SA (0DYQ)?
Revenue at Cegedim SA is growing −2.6% versus a year earlier (3y avg +5.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Cegedim SA (0DYQ)?
Earnings per share at Cegedim SA are growing +87.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Cegedim SA (0DYQ) generate?
The free cash flow of Cegedim SA is €120M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Cegedim SA (0DYQ) carry?
The net debt of Cegedim SA is €232M (fiscal year 2025, ≈ 1.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Continue in the live analysis

Fair value and trend for 35,000+ stocks, watchlist, comparison and the diversification check. You can also try 14 days of Pro there, no card.

Open the live analysis →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.